الاختبارات في نقطة الرعاية الجزيئية: الريادة في عصر جديد من التشخيص الفوري

في المشهد سريع التطور للتكنولوجيا الطبية, اختبار نقطة الرعاية الجزيئية (نقطة الرعاية) تبرز كنجم ساطع في مجال التشخيص الطبي. عن طريق دمج استخراج الحمض النووي, التضخيم, and detection into a single, closed, and portable device, Molecular POCT has simplified the diagnostic process while effectively minimizing the risk of sample contamination. This innovative approach promises faster and more accurate diagnostic capabilities.

Technical Principles: A Perfect Blend of Miniaturization and High Efficiency

The core technologies of Molecular POCT include real-time fluorescent PCR (qPCR) and Loop-Mediated Isothermal Amplification (خروف). qPCR, known for its high sensitivity and specificity, is widely used in infectious disease detection, such as screening for COVID-19, influenza, and tuberculosis. خروف, على الجانب الآخر, requires no complex thermal cycling equipment, making it a fast and suitable option for primary healthcare settings. بالإضافة إلى ذلك, the latest research has combined microfluidic chips with CRISPR/Cas12a technology, enabling physical separation of the isothermal amplification and detection processes, thereby further enhancing sensitivity and accuracy.

سيناريوهات التطبيق: Comprehensive Coverage from Hospitals to Homes

The applications of Molecular POCT are incredibly diverse, spanning emergency departments in hospitals, primary healthcare units, and home health monitoring. In ICU wards, Molecular POCT can rapidly provide diagnostic results, buying valuable time for critically ill patients. In outpatient and emergency laboratories, its modular design and on-demand testing capabilities meet the needs of patients requiring quick diagnostics. علاوة على ذلك, Molecular POCT is widely used in community healthcare, health check-up centers, customs quarantine, and food safety testing.

Market Trends: High-Speed Growth Driven by Technological Innovation

في السنوات الأخيرة, the Molecular POCT market has experienced rapid growth. في 2023, the global sales of POCT molecular diagnostic technologies reached $5.683 billion, with projections indicating it will reach $10.128 مليار بواسطة 2030. In China, the market is also expanding swiftly, مع أ 2023 market size of $266 million, expected to grow to $711 million by 2030. As technology continues to advance and application scenarios expand, Molecular POCT is becoming an indispensable part of the medical diagnostics landscape.

النظرة المستقبلية: Intelligent POCT Leading the Way in Healthcare

With the integration of emerging technologies such as artificial intelligence and the Internet of Things, Molecular POCT is poised to become even smarter and more precise. These devices will not only enable remote operation and data sharing but also provide support for medical decision-making through cloud-based platforms. From epidemic control to chronic disease management, from community healthcare to home health monitoring, the future of Molecular POCT is bright, offering endless possibilities for human health.

الاختبارات في نقطة الرعاية الجزيئية, as a leading-edge representative of instantaneous diagnostic technology, is transforming the future of medical diagnostics with its efficiency, راحة, and accuracy.

مزود

شركة شنغهاي لينغجون للتكنولوجيا الحيوية, المحدودة.تأسست في 2016 وهي شركة متخصصة في تصنيع المواد المغناطيسية الحيوية وكواشف استخلاص الحمض النووي.

لدينا خبرة غنية في استخراج وتنقية الحمض النووي, تنقية البروتين, فصل الخلايا, التألق الكيميائي, وغيرها من المجالات التقنية.

منتجاتنا تستخدم على نطاق واسع في العديد من المجالات, مثل الفحوصات الطبية, الاختبارات الجينية, البحوث الجامعية, التكاثر الوراثي, وهكذا. نحن لا نقدم المنتجات فحسب، بل يمكننا أيضًا إجراء تصنيع المعدات الأصلية, أوديإم, وغيرها من الاحتياجات. إذا كان لديك حاجة ذات صلة, لا تتردد في الاتصال بنا .